Kite Pharma shares soar after cancer therapy study shows good results

An experimental gene therapy that turns a patient's own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, Kite Pharma Inc. said Tuesday.

In all, 82% of patients had their...